These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10956543)

  • 1. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B.
    Cuevas C; Pérez M; Martín MJ; Chicharro JL; Fernández-Rivas C; Flores M; Francesch A; Gallego P; Zarzuelo M; de La Calle F; García J; Polanco C; Rodríguez I; Manzanares I
    Org Lett; 2000 Aug; 2(16):2545-8. PubMed ID: 10956543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new, more efficient, and effective process for the synthesis of a key pentacyclic intermediate for production of ecteinascidin and phthalascidin antitumor agents.
    Martinez EJ; Corey EJ
    Org Lett; 2000 Apr; 2(7):993-6. PubMed ID: 10768205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.
    Martinez EJ; Owa T; Schreiber SL; Corey EJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3496-501. PubMed ID: 10097064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins.
    Jin W; Metobo S; Williams RM
    Org Lett; 2003 Jun; 5(12):2095-8. PubMed ID: 12790537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
    Wright BJ; Chan C; Danishefsky SJ
    J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of ecteinascidin 743.
    Endo A; Yanagisawa A; Abe M; Tohma S; Kan T; Fukuyama T
    J Am Chem Soc; 2002 Jun; 124(23):6552-4. PubMed ID: 12047173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies directed to the total synthesis of ET 743 and analogues thereof: an expeditious route to the ABFGH subunit.
    Zhou B; Guo J; Danishefsky SJ
    Org Lett; 2002 Jan; 4(1):43-6. PubMed ID: 11772086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids.
    Martinez EJ; Corey EJ
    Org Lett; 1999 Jul; 1(1):75-7. PubMed ID: 10822537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical synthesis of the ABC ring model of ecteinascidins.
    Saito N; Tachi M; Seki R; Kamayachi H; Kubo A
    Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1549-57. PubMed ID: 11045468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of ecteinascidin 743.
    Chen J; Chen X; Bois-Choussy M; Zhu J
    J Am Chem Soc; 2006 Jan; 128(1):87-9. PubMed ID: 16390134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin: ET 743, ecteinascidin 743, Yondelis.
    Drugs R D; 2003; 4(1):75-81. PubMed ID: 12568645
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereospecific formal total synthesis of ecteinascidin 743.
    Zheng S; Chan C; Furuuchi T; Wright BJ; Zhou B; Guo J; Danishefsky SJ
    Angew Chem Int Ed Engl; 2006 Mar; 45(11):1754-9. PubMed ID: 16496274
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased DNA binding specificity for antitumor ecteinascidin 743 through protein-DNA interactions?
    García-Nieto R; Manzanares I; Cuevas C; Gago F
    J Med Chem; 2000 Nov; 43(23):4367-9. PubMed ID: 11087561
    [No Abstract]   [Full Text] [Related]  

  • 15. Further insight into the DNA recognition mechanism of trabectedin from the differential affinity of its demethylated analogue ecteinascidin ET729 for the triplet DNA binding site CGA.
    Marco E; David-Cordonnier MH; Bailly C; Cuevas C; Gago F
    J Med Chem; 2006 Nov; 49(23):6925-9. PubMed ID: 17154523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650.
    Martinez EJ; Corey EJ; Owa T
    Chem Biol; 2001 Dec; 8(12):1151-60. PubMed ID: 11755394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic studies on Et-743. Assembly of the pentacyclic core and a formal total synthesis.
    Fishlock D; Williams RM
    J Org Chem; 2008 Dec; 73(24):9594-600. PubMed ID: 18687003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
    Cuevas C; Francesch A
    Nat Prod Rep; 2009 Mar; 26(3):322-37. PubMed ID: 19240944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action.
    Aune GJ; Furuta T; Pommier Y
    Anticancer Drugs; 2002 Jul; 13(6):545-55. PubMed ID: 12172500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecteinascidin-743.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2003; 7(3):313-9. PubMed ID: 12793338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.